| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2973496 | The Journal of Heart and Lung Transplantation | 2006 | 8 Pages |
Abstract
Irreversible enzymatic inhibition of DPP IV has been shown to abrogate acute pulmonary rejection, maintain pulmonary function, and preserve histomorphologic architecture. These results extend earlier findings and illustrate the role of CD26/DPP IV in alloantigen-mediated immune responses.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Florian Johannes MD, Lin MD, Ingrid PhD, Koen PhD, Markus MD, Sven MD, Peter MD, Didier MD, Simon PhD, Walter MD, Stephan MD,